Skip to Main Content
Mestag Therapeutics
Menu Button
  • About
    • Team
    • Investors
  • Science
    • Our Approach
    • Partners
    • Publications
  • Life at Mestag
    • Our Culture
    • Team Mestag
    • Opportunities
  • News
  • Contact
Lines

Press Releases

  • Press Releases
Mestag Therapeutics appoints Prof. Ton Logtenberg as Chair
December 20, 2022
Read More
Mestag Therapeutics founding investigator Prof. David A. Tuveson elected to US National Academy of Medicine
October 20, 2022
Read More
Fierce Biotech names Mestag Therapeutics as one of its “Fierce 15” Biotech Companies of 2021
September 27, 2021
Read More
Mestag Therapeutics Extends Seed Financing to $45 Million and Welcomes New Investors Forbion, GV (formerly Google Ventures) and Northpond Ventures
August 3, 2021
Read More
Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease
May 18, 2021
Read More
Mestag Therapeutics launches with seed financing of $11 million to develop therapeutics targeting activated fibroblast populations across inflammatory disease and cancer
April 21, 2021
Read More
Mestag Therapeutics congratulates Founder Professor David A. Tuveson upon his appointment as 2021 President of The American Association for Cancer Research
April 12, 2021
Read More
Mestag Therapeutics
  • About
  • Science
  • Life at Mestag
  • News
  • Contact
  • Privacy Policy
  • Twitter
  • LinkedIn